A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Conditions:   Non-Small Cell Lung Cancer;   Ovarian Cancer;   Fallopian Tube Cancer;   Triple Negative Breast Cancer;   Multiple Myeloma;   Pancreatic Ductal Adenocarcinoma Interventions:   Biological: CART-TnMUC1;   Drug: Cyclophosphamide;   Drug: Fludarabine Sponsor:   Tmunity Therapeutics Not yet recruiting

Source: ClinicalTrials.gov - July 18, 2019 Category: Research Source Type: clinical trials